European Pharmaceutical Review Issue 3 2021
Posted: 23 June 2021 | European Pharmaceutical Review | No comments yet
In this journal, features on the current regulatory positions on nitrosamine impurities, how investing in off-patent medicines can help drive innovation and why new regulations could lead to a biosimilar boom in the UK. Other articles include an exploration of the challenges in developing and delivering lipid nanoparticle mRNA-based vaccines, how software can be used to improve pharma development output and so much more…
Issue 3 also features:
- BIOPROCESSING & BIOPRODUCTION
O-glycan analysis of therapeutic proteins enabled by O-glycoprotease
Xiaofeng Shi, Saulius Vainauskas and Christopher H Taron, New England Biolabs (NEB) - NMR
Solid- and Liquid-State NMR for monitoring of polysaccharide antigen in the manufacturing process
Francesco Berti, GSK Vaccines - DIGITAL TRANSFORMATION
The role of digital transformation in achieving Pharma 4.0
Saly Romero-Torres, Thermo Fisher Scientific
This issue also includes our Application Note Supplement 2021:
- Software that makes Data Integrity Compliance visible: Shimadzu LabSolutions database (DB) or client/server software (CS) combining reliability and productivity
Shimadzu - The Monocyte Activation Assay: The benefits of an animal-free test to show pyrogen-free pharmaceutical products
Nelson Labs - From our platforms to your pen injector
Nemera
The rest of this content is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Issue
Related topics
Biologics, Biosimilars, Data integrity, Drug Development, Drug Manufacturing, Formulation, Informatics, Lab Automation, Nuclear magnetic resonance (NMR), Nuclear Magnetic Resonance (NMR) spectrometry, QA/QC, Regulation & Legislation, Research & Development (R&D), Vaccine Technology, Vaccines
